Opdualag Approved for Unresectable, Metastatic Melanoma
The Food and Drug Administration (FDA) has approved Opdualag (nivolumab and relatlimab-rmbw) for the treatment of patients 12 years of age and older with unresectable or metastatic melanoma. Opdualag is a fixed-dose combination of nivolumab,…